Mir Hashim
About Mir Hashim
Mir Hashim - Chief Scientific Officer
Mir Hashim currently serves as the Chief Scientific Officer, bringing over 30 years of pharmaceutical research and development experience. He has a storied career in drug discovery and development, international regulatory submissions, and product development on a global scale. His leadership extends to in-licensing and out-licensing of drug candidates, underscoring his versatile role in the pharmaceutical landscape.
Mir Hashim's Educational Background in Biology and Pharmacology
Mir Hashim's academic journey began with a B.S. in Biology and Chemistry from Osmania University, India. He then pursued an M.S. in Biology from the Central University of Hyderabad, India, followed by a PhD in Medicine/Pharmacology from Memorial University, St. John's, Canada. His educational background has equipped him with a strong foundation in biological sciences and pharmacology, essential for his extensive career in pharmaceutical research and development.
Experience at Glaxo Smith Kline
Mir Hashim spent 18 years at Glaxo Smith Kline (GSK), where he held various influential positions. Most notably, he served as the head of Pharmacology during his tenure. His work at GSK involved significant contributions to a broad spectrum of drug discovery and development projects, preparing and submitting documentation for international regulatory approval, and overseeing product development processes.
Expertise in Drug Discovery and Therapeutic Areas
Mir Hashim possesses a comprehensive understanding of pharmacology and physiology, spanning various therapeutic areas. His expertise includes but is not limited to, central nervous system (CNS) disorders, cardiovascular diseases, gastrointestinal issues, anesthesia, and metabolic diseases such as diabetes and obesity. This breadth of knowledge enables him to navigate complex drug discovery and development processes efficiently.
Experience with In-Licensing and Out-Licensing of Drug Candidates
In addition to his research and development expertise, Mir Hashim has considerable experience in the in-licensing and out-licensing of drug candidates. This role involves evaluating potential drug candidates from other entities and negotiating their acquisition or partnering for further development. His skill in this area aids in the expansion and diversification of the company's drug portfolio.